Canaccord Genuity Reiterates a 'Buy' on GenMark Diagnostics (GNMK); Secondary Completed

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. DE

July 2, 2012 8:22 AM EDT
Get Alerts GNMK Hot Sheet
Price: $24.04 --0%

Rating Summary:
    2 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on GenMark Diagnostics (NASDAQ: GNMK) price target of $12.00.

Analyst, Jeffrey Frelick, said, "We reiterate our rating on shares of GNMK after the company recently completed a secondary offering to support its Next-Gen strategy. GNMK issued 10M shares of common stock with net proceeds of approximately $39.3M...We reduced our loss per share estimate to reflect the recent offering
and higher share count."

For an analyst ratings summary and ratings history on GenMark Diagnostics click here. For more ratings news on GenMark Diagnostics click here.

Shares of GenMark Diagnostics closed at $4.34 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View

Related Entities

Canaccord Genuity